BRD4 and neoplasm: By utilizing the unique characteristics of the tumor microenvironment, this region-confined PROTAC system enhanced the degradation of BRD4 and amplified the antitumor efficacy of ARV-771, which is activated by the stimuli-responsive system within tumor cells (Figure 3b,c).